BRCA1 and ovarian carcinoma: Detailed phenotypic and cellular characterization of one patient provided lines of evidence supporting the hypothesis that biallelic BRCA1 (FANCS) mutations cause a new Fanconi anemia subtype associated with increased breast and ovarian cancer susceptibility [42].